Recent Decisions of the Competition Authorities Regarding Behavioral Remedies: A Comparative Study of Turkey, the EU and the US

The Second Academic Gift Book of ELIG Gürkaynak Attorneys-at-Law on Selected Contemporary Competition Law Matters 35-86 (2019), ISBN: 978-605-315-352-8

62 Pages Posted: 13 Jun 2019

See all articles by Gonenc Gurkaynak

Gonenc Gurkaynak

ELIG Gürkaynak Attorneys-at-Law

Sinem Ugur

affiliation not provided to SSRN

Date Written: March 2019

Abstract

Mergers may lead to certain competitive harms that are prohibited by virtually every merger control regime in the world. To avoid the outright prohibition of a transaction that is expected to both raise several competition concerns and create pro-competitive efficiencies, the transaction may be modified through various remedies in order to eliminate the expected competitive risks without also losing its other benefits and expected efficiencies arising from the transaction (such as improved product/service quality, greater choice for consumers and increased innovation, among others).

The identification of a remedy suitable to the envisaged competitive detriments of a proposed transaction is a sensitive and complicated issue, which necessitates a detailed analysis of the transaction itself and the markets affected by the transaction. For this purpose, and depending on the particular competition risks that a transaction may lead to (such as whether they are of a vertical or horizontal nature), remedies may be imposed to modify the transaction and thereby eliminate the competition concerns.

This article aims to identify and analyze the approach of the competition authorities in Turkey, the European Union and the United States with regard to behavioral remedies. We will first describe the general features, characteristics, scope and effects of behavioral remedies and clarify these issues from the perspective of the competition enforcers and judicial authorities in the above-mentioned three jurisdictions. Subsequently, we will offer information and analysis on the most recent cases in the United States, the European Union and Turkey in order to provide some guidance for a comparative assessment of these jurisdictions. Accordingly, we will offer our evaluations of the policy implementations (stemming from the relevant legislations and regulatory/judicial decisions) in these jurisdictions.

Keywords: behavioral remedies, US, EU, Turkey, comparative, antitrust

JEL Classification: K21, L40

Suggested Citation

Gurkaynak, Gonenc and Ugur, Sinem, Recent Decisions of the Competition Authorities Regarding Behavioral Remedies: A Comparative Study of Turkey, the EU and the US (March 2019). The Second Academic Gift Book of ELIG Gürkaynak Attorneys-at-Law on Selected Contemporary Competition Law Matters 35-86 (2019), ISBN: 978-605-315-352-8, Available at SSRN: https://ssrn.com/abstract=3396738

Gonenc Gurkaynak (Contact Author)

ELIG Gürkaynak Attorneys-at-Law ( email )

Çitlenbik Sokak No:12
Yıldız Mahallesi
Istanbul, Beşiktaş 34349
Turkey

Sinem Ugur

affiliation not provided to SSRN

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
14
Abstract Views
118
PlumX Metrics